Viewing Study NCT00736333


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2025-12-26 @ 1:28 AM
Study NCT ID: NCT00736333
Status: COMPLETED
Last Update Posted: 2014-11-05
First Post: 2008-07-25
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED)
Sponsor: Merck Sharp & Dohme LLC
Organization: